Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Avigen, Inc. > News item |
Avigen files $200 million shelf
By Susanna Moon
Chicago, June 28 - Avigen, Inc. registered to sell up to $200 million of securities in an S-3 filing with the Securities and Exchange Commission.
Covered by the shelf are common stock, preferred stock, debt securities and warrants. Securities may be issued as convertibles.
Proceeds will be used for research and development and for general corporate purposes.
Avigen is a biopharmaceutical company based in Alameda, Calif.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.